Viewing data from:

CARISOPRODOL

ANDA

CARISOPRODOL | A207237 | MPP PHARMA LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: SOMA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.3777

per ea

Lowest NADAC/Unit

$0.0660

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69367041901CARISOPRODOL 250 MG TABLET	$0.3777	EA	Generic	—	2026-06-17
69367042001CARISOPRODOL 350 MG TABLET	$0.0660	EA	Generic	—	2026-06-17
69367042005CARISOPRODOL 350 MG TABLET	$0.0660	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs10 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

OLON SPACARISOPRODOL

DMF 44161982

SIEGFRIED EVIONNAZ SACARISOPRODOL

DMF 52401984

UQUIFA ITALIA SPACARISOPRODOL USP

DMF 174442004

APITORIA PHARMA PRIVATE LTDCARISOPRODOL USP

DMF 193882006

HARMAN FINOCHEM LTDCARISOPRODOL USP

DMF 210642007

SOLARA ACTIVE PHARMA SCIENCES LTDCARISOPRODOL USP

DMF 231002009

CHEMECA DRUGS PRIVATE LTDCARISOPRODOL USP

DMF 351492020

WARD BLENKINSOP AND CO LTDInactiveCARISOPRODOL

DMF 51811983

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactiveCARISOPRODOL

DMF 174002004

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCARISOPRODOL USP (ACTIVE SUBSTANCE)

DMF 191612006

ISOCHEM SASInactiveCARISOPRODOL

DMF 194082006

FLEMING LABORATORIES LTDInactiveCARISOPRODOL USP

DMF 198012006

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDInactiveCARISOPRODOL USP

DMF 199192006

ALP PHARM BEIJING CO LTDInactiveCARISOPRODOL (DRUG SUBSTANCE, NON-STERILE)

DMF 221182008

UQUIFA MEXICO SA DE CVInactiveCARISOPRODOL

DMF 245462011

POLYDRUG LABORATORIES PVT LTDInactiveCARISOPRODOL

DMF 256872012

FLEMING LABORATORIES LTDInactiveCARISOPRODOL USP

DMF 319652017

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 250MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 11, 2017

No patent or exclusivity listings for this strength.

#002 — 350MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 21, 2020